Boxplots (Figure 5C) compare the expression levels of key genes (EPB41, UBA52, GUCD1, MRC2, PLVAP, BNIP3L, TFDP1, TNFSF10, and TMCC2) between control and sepsis patients, with most genes showing significantly higher expression in sepsis patients, highlighting their potential as biomarkers or therapeutic targets. This evidence concerns the gene MRC2 and Sepsis.